Histopathological and prognostic significance of the expression of sex hormone receptors in bladder cancer: A meta-analysis of immunohistochemical studies
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Histopathological and prognostic significance of the expression of sex hormone receptors in bladder cancer: A meta-analysis of immunohistochemical studies
Authors
Keywords
-
Journal
PLoS One
Volume 12, Issue 3, Pages e0174746
Publisher
Public Library of Science (PLoS)
Online
2017-04-01
DOI
10.1371/journal.pone.0174746
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Expression of steroid hormone receptors and its prognostic significance in urothelial carcinoma of the upper urinary tract
- (2016) Eiji Kashiwagi et al. CANCER BIOLOGY & THERAPY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Estrogen Pathway: Estrogen Receptor-α, Progesterone Receptor, and Estrogen Receptor-β Expression in Radical Cystectomy Urothelial Cell Carcinoma Specimens
- (2015) Winston Tan et al. Clinical Genitourinary Cancer
- Estrogen receptor alpha prevents bladder cancer via INPP4B inhibited akt pathway in vitro and in vivo
- (2015) Oncotarget
- Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments
- (2014) Carson Ka-Lok Lo et al. BMC Medical Research Methodology
- Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transition
- (2014) Yifeng Jing et al. CANCER LETTERS
- Sex steroids and gender differences in nonmuscle invasive bladder cancer
- (2014) Ilaria Lucca et al. CURRENT OPINION IN UROLOGY
- Androgen receptor immunohistochemistry in genitourinary neoplasms
- (2014) Elizabeth M. Williams et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Prognostic Value of Sex-Hormone Receptor Expression in Non-Muscle-Invasive Bladder Cancer
- (2014) Jong Kil Nam et al. YONSEI MEDICAL JOURNAL
- Contemporary Gender-Specific Outcomes in Germany After Radical Cystectomy for Bladder Cancer
- (2014) Marianne Schmid et al. Current Urology Reports
- Suppression of ERβ signaling via ERβ knockout or antagonist protects against bladder cancer development
- (2013) Iawen Hsu et al. CARCINOGENESIS
- Role of oestrogen receptors in bladder cancer development
- (2013) Iawen Hsu et al. Nature Reviews Urology
- Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder
- (2012) Hiroshi Miyamoto et al. BJU INTERNATIONAL
- Nuclear Hormone Receptor Signals as New Therapeutic Targets for Urothelial Carcinoma
- (2012) H. Miyamoto et al. CURRENT CANCER DRUG TARGETS
- The Role of the Androgen Receptor in the Development and Progression of Bladder Cancer
- (2012) Y. Li et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Androgen Receptor Signaling Regulates Cell Growth and Vulnerability to Doxorubicin in Bladder Cancer
- (2012) Masaki Shiota et al. JOURNAL OF UROLOGY
- CD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated
- (2012) J. B. Overdevest et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder
- (2012) Luis A. Kluth et al. WORLD JOURNAL OF UROLOGY
- Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells
- (2011) Y. Zheng et al. ENDOCRINE-RELATED CANCER
- Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer
- (2011) Eric C. Kauffman et al. MOLECULAR CARCINOGENESIS
- Impact of gender on bladder cancer incidence, staging, and prognosis
- (2011) Harun Fajkovic et al. WORLD JOURNAL OF UROLOGY
- Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study
- (2010) Carmen Mir et al. BJU INTERNATIONAL
- Female bladder cancer: incidence, treatment, and outcome
- (2010) Emil Scosyrev et al. CURRENT OPINION IN UROLOGY
- Inverse expression of estrogen receptor-β and nuclear factor-κB in urinary bladder carcinogenesis
- (2010) Stylianos Kontos et al. INTERNATIONAL JOURNAL OF UROLOGY
- Expression Signature of E2F1 and Its Associated Genes Predict Superficial to Invasive Progression of Bladder Tumors
- (2010) Ju-Seog Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Androgen Receptor Is a Potential Therapeutic Target for Bladder Cancer
- (2010) Ji-Tao Wu et al. UROLOGY
- Estrogen and Progesterone Hormonal Receptor Expression in Urothelial Carcinoma of the Bladder
- (2009) Christian Bolenz et al. EUROPEAN UROLOGY
- Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: A comparative analysis of clinicopathological features and survival outcomes according to receptor expression
- (2009) Can Tuygun et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Roles of estrogen receptor and in modulating urothelial cell proliferation
- (2008) J. Teng et al. ENDOCRINE-RELATED CANCER
- Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder
- (2008) Stephen A Boorjian et al. ENDOCRINE-RELATED CANCER
- Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1
- (2008) Aimee M Johnson et al. BMC Urology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started